3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
2
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Hypoxia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Magnetic Resonance Spectroscopy
23
Metformin
14
pembrolizumab
12
Radiotherapy
12
Biopsy
11
Nivolumab
9
Fluorouracil
9
Cyclophosphamide
9
Temozolomide
7
Radiation
7
Bevacizumab
7
gallium 68 PSMA-11
6
Sirolimus
6
Rituximab
6
Letrozole
6
Etoposide
6
Cisplatin
6
Aspirin
6
olaparib
5
Surveys and Questionnaires
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Indocyanine Green
5
Granulocyte Colony-Stimulating Factor
5
Fluorodeoxyglucose F18
5
Dexamethasone
5
aldesleukin
4
Surgical Procedures, Operative
4
Proflavine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Completed
×
Atovaquone
×
Clear all
NCT03568994
2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
26 enrolled
NCT02628080
2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1
Completed
46 enrolled